Non-Hodgkin Lymphoma
News
Drug receives breakthrough designation for DLBCL
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to MOR208, an Fc-enhanced monoclonal antibody directed...
News
EMA recommends orphan designation for G100 to treat FL
The European Medicines Agency’s (EMA’s) Committee for Orphan Medicinal Products has recommended orphan designation for G100 for the treatment of...
News
New assay may aid diagnosis, treatment of DLBCL
A new assay may help improve the diagnosis and treatment of diffuse large B-cell lymphoma (DLBCL), according to researchers. The gene expression...
News
What we don’t know about BIA-ALCL
Results of a systematic review suggest a need for more research and long-term follow-up of patients with breast implant-associated anaplastic...
News
CAR T-cell therapy approved to treat lymphomas
The US Food and Drug Administration (FDA) has approved axicabtagene ciloleucel (Yescarta™, formerly KTE-C19) for use in adults with relapsed or...
News
Gel shows promise for treating early stage MF
LONDON—Results of a phase 2 trial suggest the topical histone deacetylase (HDAC) inhibitor remetinostat can elicit responses in patients with...
News
Natural selection opportunities tied to cancer rates
Countries with the lowest opportunities for natural selection have higher cancer rates than countries with the highest opportunities for natural...
News
NCCN completes resource on radiation therapy
The National Comprehensive Cancer Network® (NCCN) has announced the release of the newly completed NCCN Radiation Therapy Compendium™. This...
News
Predicting neurotoxicity after CAR T-cell therapy
Researchers say they have identified potential biomarkers that may be used to help identify patients at an increased risk of neurotoxicity after...
News
Immunotherapy demonstrates potential for T-cell lymphoma
Researchers have reported successful inhibition of the phosphatase SHIP1, which may be an effective approach for treating T-cell lymphoma. The...
News
Team identifies genetic drivers of DLBCL
Research published in Cell has revealed 150 genetic drivers of diffuse large B-cell lymphoma (DLBCL). Among these drivers are 27 genes newly...